» Authors » Arnaud D Kaze

Arnaud D Kaze

Explore the profile of Arnaud D Kaze including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 915
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaze A, Bertoni A, Fox E, Hall M, Mentz R, Berry J, et al.
Diabetes Care . 2025 Jan; 48(3):464-472. PMID: 39761430
Objective: To assess the extent to which the concomitant presence of subclinical myocardial injury or stress and diabetes affects the risk of heart failure (HF) subtypes. Research Design And Methods:...
2.
Noumegni S, Kaze A, Bertoni A, Fonarow G, Echouffo-Tcheugui J
Diabetes Care . 2024 Sep; 47(11):e88-e89. PMID: 39230990
No abstract available.
3.
Kaze A, Bertoni A, Fox E, Hall M, Mentz R, Echouffo-Tcheugui J
Eur J Heart Fail . 2024 Sep; PMID: 39225160
Aims: The extent to which metabolic syndrome (MetS) severity influences subclinical myocardial remodelling, heart failure (HF) incidence and subtypes, remains unclear. We assessed the association of MetS with incident HF...
4.
Kaze A, Santhanam P, Ahima R, Bertoni A, Echouffo-Tcheugui J
Diabetes Care . 2024 Jun; 47(8):1408-1414. PMID: 38837904
Objective: Little is known about the extent to which microvascular disease is associated with cardiorespiratory fitness (CRF) among individuals with type 2 diabetes. Research Design And Methods: A total of...
5.
Kazibwe R, Singleton M, Ahmad M, Kaze A, Chevli P, Namutebi J, et al.
Am J Prev Cardiol . 2023 Nov; 16:100610. PMID: 37942025
Objective: The effect of body weight variability (BWV) and body weight change (BWC) in high-risk individuals with hypertension, but without diabetes mellitus (DM) remains unclear. We examined the effect of...
6.
Kaze A, Fonarow G, Echouffo-Tcheugui J
J Am Heart Assoc . 2023 Oct; 12(20):e029814. PMID: 37830346
Background There is a paucity of large-scale epidemiological studies on the link between cardiac autonomic neuropathy (CAN) and the risk of silent myocardial infarction (SMI) in type 2 diabetes. We...
7.
Kazibwe R, Singleton M, Chevli P, Kaze A, Namutebi J, Shapiro M, et al.
Am J Prev Cardiol . 2023 Aug; 16:100524. PMID: 37576387
Objective: Engaging in physical activity (PA) is recommended to reduce the risk of morbidity and mortality in patients with hypertension. However, the association between PA and clinical outcomes in individuals...
8.
Kaze A, Yuyun M, Fonarow G, Echouffo-Tcheugui J
JACC Adv . 2023 Jul; 2(4). PMID: 37427148
Background: There is a paucity of epidemiological data on the association between long-term variability of blood pressure (BP) and incident atrial fibrillation (AF). Objectives: The purpose of this study was...
9.
Kaze A, Patorno E, Paik J
Curr Opin Nephrol Hypertens . 2023 May; 32(4):324-329. PMID: 37195239
Purpose Of Review: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) represent a relatively new class of oral glucose-lowering agents that reduce adverse cardiovascular and kidney outcomes among individuals with chronic kidney disease...
10.
Kaze A, Yuyun M, Fonarow G, Echouffo-Tcheugui J
Eur Stroke J . 2023 Apr; 8(1):275-282. PMID: 37021204
Introduction: There is a dearth of data on the association between cardiac autonomic neuropathy (CAN) with incident stroke among individuals with diabetes mellitus. We evaluated this association in a large...